Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News Prescient Therapeutics gets FDA orphan drug status for PTX-100 in PTCL Prescient Therapeutics has secured the orphan drug designation for its PTX-100 compound from the US Food and Drug… bySrinathJuly 15, 2022